pirfenidone has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Nong, L; Wang, M; Wang, R | 1 |
| Oku, H; Tokura, T; Tsukamoto, Y | 1 |
2 other study(ies) available for pirfenidone and Skin Neoplasms
| Article | Year |
|---|---|
Multiple eruptive dermatofibromas aggravated by mycophenolate mofetil and pirfenidone in a patient with systemic sclerosis.
Topics: Antirheumatic Agents; Female; Histiocytoma, Benign Fibrous; Humans; Lung Diseases, Interstitial; Middle Aged; Mycophenolic Acid; Pyridones; Scleroderma, Systemic; Skin; Skin Neoplasms | 2020 |
[Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Gastrointestinal Diseases; Humans; Idiopathic Pulmonary Fibrosis; Photosensitivity Disorders; Pyridones; Skin Neoplasms | 2009 |